Novo Nordisk A/S delivered mixed Q3 '25 results, with modest revenue growth but 27% drop in net profit due to financing costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback